Arteriosclerosis, Vol 8, 46-56, Copyright © 1988 by American Heart Association

ARTICLES

Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism

G Schmitz, H Robenek, M Beuck, R Krause, A Schurek and R Niemann
Institute for Clinical Chemistry, Westfalische-Wilhelms-University, Munster, West Germany.

The effects of the slow Ca++ channel blocker, nifedipine, and ACAT inhibitor, octimibate, on the cholesterol metabolism of cholesterol- loaded macrophages were compared. We demonstrated that apolipoprotein A- I containing high density lipoproteins (HDL) bind to specific receptor sites on macrophages, are internalized, take up cholesterol, and are then released from the cells as native lipoproteins. The ACAT inhibitor enhances HDL receptor activity and promotes HDL-mediated cholesterol efflux from cultured mouse peritoneal macrophages. In contrast, the Ca++ antagonist increases acetyl LDL-mediated cholesterol influx, abolishes the increase in HDL binding induced by cholesterol accumulation, enhances apo E synthesis, and promotes cholesterol efflux by a mechanism independent of the presence of HDL in the surrounding medium. Concomitantly, a decrease in nucleoside transporter activity, an increase in intracellular ATP hydrolysis, adenosine and cyclic AMP concentration, and a stimulation of the activities of acid and neutral cholesteryl ester hydrolase and ACAT indicated that protein kinase A- catalyzed phosphorylation reactions might be involved in the increase in cholesterol efflux. The Ca++ antagonist-induced efflux occurred only with lysosomal-associated cholesterol, while the ACAT inhibitor acted on the formation of cytoplasmic lipid droplets. The secreted lipoprotein particles contained 68% unesterified cholesterol and 21% phospholipids, 8% esterified cholesterol, and 3% triglycerides. The phospholipid components were: 72% phosphatidylcholine, 22% sphingomyelin, and 6% phosphatidylserine, phosphatidylinositol, and phosphatidylethanolamine. We conclude that macrophages release cholesterol in two ways: 1) an HDL-mediated release of unesterified cholesterol increasing upon ACAT inhibition, and 2) an HDL-independent secretion of cholesterol which can be amplified by Ca++ antagonists.

This article has been cited by other articles:

				H. S. Kruth, I. Ifrim, J. Chang, L. Addadi, D. Perl-Treves, and W.-Y. Zhang Monoclonal antibody detection of plasma membrane cholesterol microdomains responsive to cholesterol trafficking J. Lipid Res., September 1, 2001; 42(9): 1492 - 1500. [Abstract] [Full Text] [PDF]

				A. Rodriguez, P. S. Bachorik, and S.-B. Wee Novel Effects of the Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibitor 58-035 on Foam Cell Development in Primary Human Monocyte–Derived Macrophages Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2199 - 2206. [Abstract] [Full Text] [PDF]

				I. Ishii, N. Yokoyama, M. Yanagimachi, N. Ashikawa, M. Hata, S. Murakami, Y. Asami, N. Morisaki, Y. Saito, S. Ohmori, et al. Stimulation of Cholesterol Release from Rabbit Foam Cells by the Action of a New Inhibitor for Acyl CoA:Cholesterol Acyltransferase (ACAT), HL-004 J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 115 - 121. [Abstract] [Full Text]

				A. Cignarella, B. Brennhausen, A. von Eckardstein, G. Assmann, and P. Cullen Differential Effects of Lovastatin on the Trafficking of Endogenous and Lipoprotein-Derived Cholesterol in Human Monocyte–Derived Macrophages Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1322 - 1329. [Abstract] [Full Text] [PDF]

				I. E. Petrichenko, D. Daret, G. V. Kolpakova, Y. A. Shakhov, and J. Larrue Glucocorticoids Stimulate Cholesteryl Ester Formation in Human Smooth Muscle Cells Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1143 - 1151. [Abstract] [Full Text]

				P. Lesnik, C. Dachet, L. Petit, M. Moreau, S. Griglio, P. Brudi, and M. J. Chapman Impact of a Combination of a Calcium Antagonist and a ß-Blocker on Cell- and Copper-Mediated Oxidation of LDL and on the Accumulation and Efflux of Cholesterol in Human Macrophages and Murine J774 Cells Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 979 - 988. [Abstract] [Full Text]

				W.-Y. Zhang, P. M. Gaynor, and H. S. Kruth Apolipoprotein E Produced by Human Monocyte-derived Macrophages Mediates Cholesterol Efflux That Occurs in the Absence of Added Cholesterol Acceptors J. Biol. Chem., November 8, 1996; 271(45): 28641 - 28646. [Abstract] [Full Text] [PDF]

				P. H.E. Groot, B. J.M. van Vlijmen, G. M. Benson, M. H. Hofker, R. Schiffelers, M. Vidgeon-Hart, and L. M. Havekes Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 926 - 933. [Abstract] [Full Text]

				J. R. Guyton and K. F. Klemp Development of the Lipid-Rich Core in Human Atherosclerosis Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 4 - 11. [Full Text]

				D. N. Mukhin, F.-F. Chao, and H. S. Kruth Glycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1607 - 1615. [Abstract] [Full Text]

				L. Kritharides, W. Jessup, E. L. Mander, and R. T. Dean Apolipoprotein A-I–Mediated Efflux of Sterols From Oxidized LDL–Loaded Macrophages Arterioscler Thromb Vasc Biol, February 1, 1995; 15(2): 276 - 289. [Abstract] [Full Text]